These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1183625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ, Deville JL, Dubois M.
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [Abstract] [Full Text] [Related]

  • 3. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA, Smith RP, Rademaker AW.
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [Abstract] [Full Text] [Related]

  • 4. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L.
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [Abstract] [Full Text] [Related]

  • 5. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 May; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fertility control with Ovral. A clinical review.
    Laurie RE, Lewis ET.
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M, Sartoretto JN.
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [Abstract] [Full Text] [Related]

  • 11. Long-term experience with a low-dose oral contraceptive.
    Brill K, Schnitker J, Albring M.
    Gynecol Endocrinol; 1990 Dec; 4(4):277-86. PubMed ID: 2150581
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O, Akinyemi A.
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [Abstract] [Full Text] [Related]

  • 14. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 15. Clinical studies with a low dose estrogen-progestogen combination.
    Sartoretto JN, Ortega-Recio JC, Moraes R, Filho FN.
    Contraception; 1977 May 01; 15(5):563-70. PubMed ID: 880827
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB, Korba VD.
    Int J Fertil; 1988 Sep 15; 33(6):406-10. PubMed ID: 2906915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.